• A new look at endometriosis: the role of restoring of full immune surveillance over ectopic cells of the endometrium
To content

A new look at endometriosis: the role of restoring of full immune surveillance over ectopic cells of the endometrium

HEALTH OF WOMAN. 2017.7(123):99–106; doi 10.15574/HW.2017.123.99

Melnikov S. M., Tatskyy O. F.
SI «Institute of Urology Academy of Medical Sciences of Ukraine», Kyiv
«Camelin-Ukraine» Foundation, «Spirika» Ltd., Kyiv

The article deals with the role of immunological disorders in the occurrence of genital endometriosis recurrences, as well as the results of treatment of this disease.
The objective: the study of the effect of restoring immune homeostasis with the help of exogenous peptides on the effectiveness of the treatment of endometriosis.
Patients and methods. Endometriosis was treated in 68 women of childbearing age. In 48 patients, uterine endometriosis (adenomyosis) was diagnosed, and 20 cases were endometriosis of the vaginal part of the cervix. In order to study the effectiveness of Camelyn-Bio in the treatment of endometriosis, patients were divided into two groups.
Results. In the group of patients who were prescribed hormonal monotherapy, 3 months after the end of the course of hormonal treatment, recurrence of endometriosis was observed. They arose due to systemic and local immunological disorders, which probably led to ectopic endometrial cells from immune surveillance.
Due to the properties of the exogenous peptides of the Camelyn-Bio preparation, reacting with the regulatory peptides of the ectopic cells of the endometrium, there are conditions for a complete immunological surveillance of the endometrium foci. In the group of patients treated with Camelyn-Bio, the incidence of relapse was 4 times lower than that of the control group.
Conclusion. Treatment of endometriosis with the combined progestogen and estragon drug is effective and contributes to a sustained regression of the clinical symptoms of the disease. A break in the use of basic hormonal therapy leads to relapses of endometriosis, which is confirmed by the instrumental methods of research. Clinical experience confirms that the restoration of the immune homeostasis of patients with the Camelyn-Bio preparation is an important factor in increasing the effectiveness of endometriosis treatment, leads to clinical remission and improves the quality of life.
Key words: endometriosis, ectopic cells of the endometrium, apoptosis, Camelyn-Bio, immune homeostasis, relapses, treatment.


1. Benyuk VO, Usevich IA. 2007. Sovremennyiy vzglyad na lechenie endometrioza. Med. aspektyi zdorovya zhenschinyi 1:28–31.

2. Zasieda YuI, Tatskyi OF. 2017. Efekt tkanynnoho nakopychennia ekzohennykh peptydiv – kliuch do rozuminnia mekhanizmiv harmonizatsii imunnoho homeostazu u patsiientiv z khronichnym bakterialnym prostatytom. Zdorove muzhchynы 1(60):51–56.

3. Kurchenko AI, Beniuk VO, Potebnia HP, Kobys VL, Tatskyi OF, Neimark SO. 2017. Rol ekzohennykh peptydiv u vidnovlenni povnotsinnoi imunnoi vidpovidi v umovakh vtorynnoho imunodefitsytu. Zdorove zhenshchynы 1(117):89–97.

4. Lytvynenko OO, Tatskyi OF. 2017. Efektyvna profilaktyka retsydyviv raku molochnoi zalozy: rol ekzohennykh peptydiv MHP u vidnovlenni imunnoho homeostazu. Klinichna imunolohiia. Alerholohiia. Infektolohiia. 3(100):51–56.

5. Linde VA, Tatarova NA, Grishanina OI. 2008. Immunologicheskie aspektyi endometrioza. Problemy reproduktsii. 14;4:74–77.

6. Badipatla KR, Vupputuri A, Niazi M, Blaise MN, Nayudua SK. 2017, Feb. Colonic Endometriosis: Dig Deeper for Diagnosis. Gastroenterology Res. 10(1):59-62. https://doi.org/10.14740/gr760e; PMid:28270880 PMCid:PMC5330696

7. Badescu A, Roman H, Aziz M, Puscasiu L, Molnar C, Huet E, Sabourin JC et al. 2016. Mapping of bowel occult microscopic endometriosis implants surrounding deep endometriosis nodules infiltrating the bowel. Fertil Steril. 105(2):430–434. https://doi.org/10.1016/j.fertnstert.2015.11.006; PMid:26613653

8. Carfagna P, De Cicco Nardone C, De Cicco Nardone A, Testa AC, Scambia G, Marana R, De Cicco Nardone F. 2017, May 15. The Role of Transvaginal Ultrasound in the Evaluation of Ureteral Involvement in Deep Endometriosis. Ultrasound Obstet Gynecol. https://doi.org/10.1002/uog.17524

9. Casals G, Ordi J, Creus M, Fбbregues F, Carmona F, Casamitjana R et al. 2012. Expression pattern of osteopontin and бvв3 integrin during the implantation window in infertile patients with early stages of endometriosis. Hum Reprod. 27:805–813. https://doi.org/10.1093/humrep/der432; PMid:22215628

10. Da Broi MG, Navarro PA. 2016. Oxidative stress and oocyte quality: ethiopathogenic mechanisms of minimal/mild endometriosis-related infertility. Cell Tissue Res. 364(1):1–7. https://doi.org/10.1007/s00441-015-2339-9; PMid:26685866

11. Facchin F, Barbara G, Saita E et al. 2016. Personality in women with endometriosis: temperament and character dimensions and pelvic pain. Hum Reprod. 31(7):1515–1521. https://doi.org/10.1093/humrep/dew108; PMid:27165626

12. Fritzer N, Haas D, Oppelt P et al. 2013. More than just bad sex: sexual dysfunction and distress in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol. 169(2):392-396. https://doi.org/10.1016/j.ejogrb.2013.04.001; PMid:23642970

13. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, Qin J, Lydon JP, DeMayo FJ, O’Malley BW. 2012. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med. 18:1102–1111. https://doi.org/10.1038/nm.2826; PMid:22660634 PMCid:PMC3541027

14. Han SJ, O’Malley BW. 2014, Jul. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Hum Reprod Update. 20(4):467–484. https://doi.org/10.1093/humupd/dmu002; PMid:24634322 PMCid:PMC4063700

15. Hansen KE, Kesmodel US, Kold M, Forman A. 2017. Long-term effects of mindfulness-based psychological intervention for coping with pain in endometriosis: a six-year follow-up on a pilot study. Nord Psychol. 69(2):100-109. https://doi.org/10.1080/19012276.2016.1181562

16. Jiang L, Yan Y, Liu Z, Wang Y. 2016. Inflammation and endometriosis. Front Biosci. 21:941–948. https://doi.org/10.2741/4431

17. Khachani I, Adib AF, Bezad R. 2017. Cesarean Scar Endometriosis: An Uncommon Surgical Complication on the Rise? Case Report and Literature Review. Case Rep Obstet Gynecol. 2017:8062924. https://doi.org/10.1155/2017/8062924; PMid:28326210 PMCid:PMC5343249

18. Köhler G, Faustmann TA, Gerlinger C. 2010. A dose — randing stady to determine the effecacy and safety of 1,2, and 4 mg of dienogest daily for endometriosis. Int. J. Gyn. Obst. 108:21–25. https://doi.org/10.1016/j.ijgo.2009.08.020; PMid:19819448

19. Laura Buggio L, Barbara G, Facchin F, Frattaruolo MP, Aimi G, Berlanda N. 2017. Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care. Int J Womens Health. 9:281-293. https://doi.org/10.2147/IJWH.S119724; PMid:28496368 PMCid:PMC5422563

20. Machairiotis N, Stylianaki A, Dryllis G et al. 2013. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagnostic Pathology 8:194. https://doi.org/10.1186/1746-1596-8-194

21. Moawad NS, Caplin A. 2013. Diagnosis, management, and long-term outcomes of rectovaginal endometriosis. Int J Womens Health. 5:753–763. https://doi.org/10.2147/IJWH.S37846; PMid:24232977 PMCid:PMC3825702

22. Montalto M, Santoro L, D’Onofrio F, Gallo A, Campo S, Campo V, Gasbarrini A et al. 2010. Endometriosis, need for a multidisciplinary clinical setting: the internist’s point of view. Intern Emerg Med. 5(6):463–467. https://doi.org/10.1007/s11739-010-0404-7; PMid:20449690

23. Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zondervan KT. 2012. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril. 98(3):670–692. https://doi.org/10.1016/j.fertnstert.2012.04.022; PMid:22657249 PMCid:PMC3679490

24. Potlog-Nahari C, Feldman AL, Stratton P, Koziol DE, Segars J, Merino MJ, Nieman LK. 2004. CD10 immunohistochemical staining enhances the histological detection of endometriosis. Fertility and sterility. 82(1):86–92. https://doi.org/10.1016/j.fertnstert.2003.11.059; PMid:15236994

25. Rana R, Sharma S, Narula H, Madhok B. 2016. A case of recto-sigmoid endometriosis mimicking carcinoma. Springerplus. 5:643. https://doi.org/10.1186/s40064-016-2221-6; PMid:27330909 PMCid:PMC4870527

26. Riћner TL. 2015. Diagnostic potential of peritoneal fluid biomarkers of endometriosis. Expert Rev Mol Diagn. 15(4):557–580. https://doi.org/10.1586/14737159.2015.1015994; PMid:25719220

27. Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano P, Candiani M, Parazzini F, Mangili G. 2014. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecologic oncology 133(3):480–484. https://doi.org/10.1016/j.ygyno.2014.03.017; PMid:24642093

28. Soave I, Caserta D, Wenger JM, Dessole S, Perino A, Marci R. 2015. Environment and endometriosis: a toxic relationship. Eur Med Pharmacol Sci. 19(11):1964–1972.

29. Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R. 2013. fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecologic oncology 128(2):260–264. https://doi.org/10.1016/j.ygyno.2012.10.023; PMid:23116937

30. Szymanowski K, Mikoіajczyk M, Wirstlein P, Dera-Szymanowska A. 2016. Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-в2 (TGF-в2) expression in eutopic endometrium of women with peritoneal endometriosis. Ann Agric Environ Med. 23(4):649–653. https://doi.org/10.5604/12321966.1226861; PMid:28030938

31. Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. 2016. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 106(7):1552–1571.e2. https://doi.org/10.1016/j.fertnstert.2016.10.022; PMid:27817837

32. Wang S, Qiu L, Lang JH, Shen K, Huang HF, Pan LY, Wu M, Yang JX, Guo LN. 2013. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. American journal of obstetrics and gynecology 209(3):241–e241-249.

33. Wolthuis AM, Meuleman C, Tomassetti C, D’Hooghe T, de Buck van Overstraeten A, D’Hoore A. 2014. Bowel endometriosis: colorectal surgeon’s perspective in a multidisciplinary surgical team. World J Gastroenterol. 20(42):15616–15623. https://doi.org/10.3748/wjg.v20.i42.15616; PMid:25400445 PMCid:PMC4229526

34. Wu MH, Shoji Y, Chuang PC, Tsai SJ. 2007. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med. 9(2):1–20. https://doi.org/10.1017/S146239940700021X; PMid:17227592

35. Zhang J, Liu X. 2016. Clinicopathological features of endometriosis in abdominal wall—clinical analysis of 151 cases. Clinical and Experimental Obstetrics and Gynecology 43(3):379–383. PMid:27328495